Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q86TM3 (
cage
)
29,987
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
DNA methylation and histone modifications play a central role in the epigenetic regulation of gene expression and cell differentiation. Recently,
Np95
(also known as UHRF1 or ICBP90) has been found to interact with Dnmt1 and to bind hemimethylated DNA, indicating together with genetic studies a central role in the maintenance of DNA methylation. Using in vitro binding assays we observed a weak preference of
Np95
and its SRA (SET- and Ring-associated) domain for hemimethylated CpG sites. However, the binding kinetics of
Np95
in living cells was not affected by the complete loss of genomic methylation. Investigating further links with heterochromatin, we could show that
Np95
preferentially binds histone H3 N-terminal tails with trimethylated (H3K9me3) but not acetylated lysine 9 via a tandem Tudor domain. This domain contains three highly conserved aromatic amino acids that form an aromatic
cage
similar to the one binding H3K9me3 in the chromodomain of HP1ss. Mutations targeting the aromatic
cage
of the
Np95
tandem Tudor domain (Y188A and Y191A) abolished specific H3 histone tail binding. These multiple interactions of the multi-domain protein
Np95
with hemimethylated DNA and repressive histone marks as well as with DNA and histone methyltransferases integrate the two major epigenetic silencing pathways.
...
PMID:The multi-domain protein Np95 connects DNA methylation and histone modification. 2002 81